메뉴 건너뛰기




Volumn 125, Issue 12, 1999, Pages 697-698

Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; PACLITAXEL; PLATINUM COMPLEX;

EID: 0032737212     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050336     Document Type: Article
Times cited : (25)

References (6)
  • 1
    • 0026023157 scopus 로고
    • Serial CA 125 levels during chemotherapy for metastatic or recurrent endometrial cancer
    • Fanning J, Piver MS (1991) Serial CA 125 levels during chemotherapy for metastatic or recurrent endometrial cancer. Obstet Gynecol 77:278-280
    • (1991) Obstet Gynecol , vol.77 , pp. 278-280
    • Fanning, J.1    Piver, M.S.2
  • 2
    • 0030968462 scopus 로고    scopus 로고
    • The role of CA-125 in the management of ovarian cancer
    • Markman M (1997) The role of CA-125 in the management of ovarian cancer. The Oncologist 2:6-9
    • (1997) The Oncologist , vol.2 , pp. 6-9
    • Markman, M.1
  • 3
    • 0025117336 scopus 로고
    • Use of serum CA 125 measurements in posttreatment surveillance of early-stage endometrial carcinoma
    • Patsner B, Orr JW Jr, Mann WJ Jr (1990) Use of serum CA 125 measurements in posttreatment surveillance of early-stage endometrial carcinoma. Am J Obstet Gynecol 162:427-429
    • (1990) Am J Obstet Gynecol , vol.162 , pp. 427-429
    • Patsner, B.1    Orr J.W., Jr.2    Mann W.J., Jr.3
  • 6
    • 0024322579 scopus 로고
    • CA 125, NB/70 K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma
    • Tseng PC, Sprance HE, Carcangiu ML, Chambers JT, Schwartz PE (1989) CA 125, NB/70 K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma. Obstet Gynecol 74:384-387
    • (1989) Obstet Gynecol , vol.74 , pp. 384-387
    • Tseng, P.C.1    Sprance, H.E.2    Carcangiu, M.L.3    Chambers, J.T.4    Schwartz, P.E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.